Inquiry list (0)
R-PSMA I&T(GMP)
R-PSMA I&T(GMP)
CAS NO : 2192281-54-0
Product No : R-PSMA I&T/Zadavotide guraxetan
Molecular Formula : C63H92IN11O23
Synonyms : (R)-DOTAGA-D-Tyr(3-1)-D-Phe-D-Lys[Sub-Lys-CO-Glu]-OH
Application : Zadavotide Guraxetan (R-PSMA I&T) is a highly specific small-molecule probe targeting the Prostate-Specific Membrane Antigen (PSMA). It can be radiolabeled with various radionuclides for positron emission tomography (PET) imaging and peptide receptor radi
- Description
Application: Zadavotide Guraxetan (R-PSMA I&T) is a highly specific small-molecule probe targeting the Prostate-Specific Membrane Antigen (PSMA). It can be radiolabeled with various radionuclides for positron emission tomography (PET) imaging and peptide receptor radionuclide therapy (PRRT), supporting precise diagnosis and targeted treatment of prostate cancer.
Molecular weight: 1498.39
Our R-PSMA I&T complies with the requirements of the European Pharmacopoeia for the Lutetium-177 Zadavotide Guraxetan Injection. The product offers high purity, stability, and full GMP documentation, meeting the stringent standards for nuclear medicine research and clinical trials.
References:
Weineisen M. et al. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies. J Nucl Med, 2015, 56(8):1169-76.
WHO. International Nonproprietary Names for Pharmaceutical Substances (INN), Proposed International Nonproprietary Names: List 132. WHO Drug Information, Vol. 38 , No. 4, 2024.